
TRP · NYSE
The supplied consensus is Hold across 19 analysts, with a mean target of $72.86; no low or high consensus targets are provided, so target clustering and the formal spread cannot be measured. Separate published snapshots are inconsistent, showing targets of $61.88, $80.67, $84, $95.36 and $96.43 across different sources and samples. The evidence does not identify the individual analysts who are most or least bullish, nor does it report any rating or target revisions during the past week. The substantive disagreement appears to center on whether recent earnings beats, 12% comparable-EBITDA growth and upper-end guidance justify a higher valuation, versus concerns about weaker FY2025 net income and the stock’s immediate post-results reversal.